Abstract:Background: Metabolism is critical for sustaining life, immunity and infection, but its role in COVID-19 is not fully understood. Methods: Seventy-nine COVID-19 patients, 78 healthy controls (HCs) and 30 COVID-19-like patients were recruited in a prospective cohort study. Samples were collected from COVID-19 patients with mild or severe symptoms on admission, patients who progressed from mild to severe symptoms, and patients who were followed from hospital admission to discharge. The metabolome was assayed using gas chromatography-mass spectrometry. Results: Serum butyric acid, 2-hydroxybutyric acid, L-glutamic acid, L-phenylalanine, L-serine, L-lactic acid, and cholesterol were enriched in COVID-19 and COVID-19-like patients versus HCs. Notably,D-fructose and succinic acid were enriched, and citric acid and 2-palmitoyl-glycerol were depleted in COVID-19 patients compared to COVID-19-like patients and HCs, and these four metabolites were not differentially distributed in non-COVID19 groups. COVID-19 patients had enriched 4-deoxythreonic acid and depleted 1,5-anhydroglucitol compared to HCs and enriched oxalic acid and depleted phosphoric acid compared to COVID-19-like patients. A combination of D-fructose, citric acid and 2-palmitoyl-glycerol distinguished COVID-19 patients from HCs and COVID-19-like patients, with an area under the curve (AUC) > 0.92 after validation. The combination of 2-hydroxy-3methylbutyric acid, 3-hydroxybutyric acid, cholesterol, succinic acid, L-ornithine, oleic acid and palmitelaidic acid predicted patients who progressed from mild to severe COVID-19, with an AUC of 0.969. After discharge, nearly one-third of metabolites were recovered in COVID-19 patients. Conclusions: The serum metabolome of COVID-19 patients is distinctive and has important value in investigating pathogenesis, determining a diagnosis, predicting severe cases, and improving treatment. (C) 2021 Elsevier Inc. All rights reserved.

Immune Response Pattern Across the Asymptomatic, Symptomatic and Convalescent Periods of COVID-19

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Proteomics Investigation of Diverse Serological Patterns in COVID-19

Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage

Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19

Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

Analysis of the Dynamic Relationship Between Immune Profiles and the Clinical Features of Patients with COVID-19

Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies

Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19

The Serum Metabolome of COVID-19 Patients is Distinctive and Predictive

Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals

Immune suppression in the early stage of COVID-19 disease

The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19

Single-cell landscape of immunological responses in patients with COVID-19

Immune Response Dynamics and Biomarkers in COVID-19 Patients

Clinical and Immunological Characteristics in COVID-19 Convalescent Patients

Complex changes in serum protein levels in COVID-19 convalescents

Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories.

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Identification of gene and protein signatures associated with long-term effects of COVID-19 on the immune system after patient recovery by analyzing single-cell multi-omics data using a machine learning approach